Theriva Biologics, Inc. (TOVX): restructuring charge — Theriva Biologics cuts 32% of workforce, expects $520K severance costs, extends cash runway into Q2 2026

Theriva Biologics, Inc.

Board approved restructuring plan to focus on business development and VCN-01 clinical trials for PDAC and retinoblastoma.
Workforce reduction of ~7 employees (32% of global workforce) implemented September 30, 2025.
Estimated $520K in cash severance and benefits charges in Q4 2025; expects ~$2M annual compensation savings.
Cash runway extended into Q2 2026 due to cost reductions and anticipated operating savings.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Theriva Biologics, Inc. announced a restructuring with charges of approximately $520,000 affecting global Company workforce (approximately seven employees or 32% of the current global Company workforce).

Type: restructuring
Charge: approximately $520,000
Affected area: global Company workforce
Headcount: approximately seven employees or 32% of the current global Company workforce

Exact text from the filing

its best opportunity for success. The Company expects to substantially complete the employee reduction immediately and estimates that it will incur a total of approximately $520,000 in charges in connection with the workforce reduction, all of which is expected to be incurred in the fourth quarter of 2025. These charges consist primarily of cash severance and

View on SEC.gov

2 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

Theriva Biologics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-096047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.